Acurx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 08/14/2025 | 1.08 M | $550.92 K | 100.00% | 4.53% |
| PROSPECT FINANCIAL SERVICES LLC | 08/08/2025 | 296.78 K | $151.59 K | -19.04% | 1.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 146.40 K | $74.79 K | -14.63% | 0.62% |
| VANGUARD GROUP INC | 08/11/2025 | 145.54 K | $74.37 K | -72.51% | 0.61% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 87.78 K | $44.84 K | 230.00% | 0.37% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 07/31/2025 | 85.00 K | $43.00 K | 466.67% | 0.36% |
| SABBY MANAGEMENT, LLC | 08/14/2025 | 81.89 K | $41.83 K | -95.99% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 69.75 K | $35.63 K | 100.00% | 0.29% |
| O'BRIEN GREENE & CO. INC | 08/06/2025 | 60.00 K | $30.65 K | 100.00% | 0.25% |
| VIRTU FINANCIAL LLC | 08/12/2025 | 55.13 K | $28.00 K | 100.00% | 0.23% |
| VANGUARD CAPITAL WEALTH ADVISORS | 07/11/2025 | 46.00 K | $23.50 K | -31.85% | 0.19% |
| ACT ADVISORS, LLC. | 07/15/2025 | 45.95 K | $23.47 K | 100.00% | 0.19% |
| STATE STREET CORP | 08/14/2025 | 43.47 K | $22.20 K | 0.00% | 0.18% |
| UBS GROUP AG | 08/14/2025 | 38.76 K | $19.81 K | 82,365.96% | 0.16% |
| XTX TOPCO LTD | 08/12/2025 | 37.69 K | $19.25 K | 100.00% | 0.16% |
| NBC SECURITIES, INC. | 07/08/2025 | 30.00 K | $15.00 K | 0.00% | 0.13% |
| JANE STREET GROUP, LLC | 08/14/2025 | 28.02 K | $14.32 K | 100.00% | 0.12% |
| NORTHERN TRUST CORP | 08/13/2025 | 27.29 K | $13.94 K | 0.00% | 0.11% |
| GPS WEALTH STRATEGIES GROUP, LLC | 08/05/2025 | 23.50 K | $12.00 K | 4,600.00% | 0.10% |
| BAADER BANK AKTIENGESELLSCHAFT | 07/10/2025 | 16.39 K | $5.17 K | 100.00% | 0.07% |
| GROUP ONE TRADING, L.P. | 08/14/2025 | 13.61 K | $6.95 K | 1,067.98% | 0.06% |
| WEALTHCARE ADVISORY PARTNERS LLC | 07/22/2025 | 11.54 K | $5.89 K | 100.00% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 09/04/2025 | 10.45 K | $5.33 K | 9.08% | 0.04% |
| QUARTZ PARTNERS, LLC | 08/14/2025 | 10.00 K | $5.11 K | 0.00% | 0.04% |
| SIMPLEX TRADING, LLC | 08/05/2025 | 6.89 K | $3.00 K | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/15/2025 | 4.16 K | $2.12 K | -5.80% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 1.35 K | $689 | 857.45% | 0.01% |
| BLACKROCK, INC. | 08/12/2025 | 1.20 K | $615 | -96.48% | 0.01% |
| SBI SECURITIES CO., LTD. | 08/08/2025 | 284 | $145 | 0.00% | 0.00% |
| SEMMAX FINANCIAL ADVISORS INC. | 08/15/2025 | 153 | $684 | -97.29% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
| CORNERSTONE PLANNING GROUP LLC | 08/11/2025 | 0 | $0 | -100.00% | 0.00% |
Acurx Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 33 institutional investors and hedge funds held shares of Acurx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Vanguard Capital Wealth Advisors: 0
Prospect Financial Services LLC: 0
GPS Wealth Strategies Group, LLC: 0
Baader Bank Aktiengesellschaft: 0
ACT Advisors, LLC.: 0
Wealthcare Advisory Partners LLC: 0
10.52% of Acurx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.09 M shares in the last 24 months. This purchase volume represents approximately $10.00 M in transactions.